Related topics

Milestone Pharmaceuticals: 3Q Earnings Snapshot

November 13, 2019

MONTREAL (AP) _ Milestone Pharmaceuticals Inc. (MIST) on Wednesday reported a loss of $12.8 million in its third quarter.

On a per-share basis, the Montreal-based company said it had a loss of 52 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MIST at https://www.zacks.com/ap/MIST